Invasive aspergillosis in children with hematologic malignancies
- PMID: 16494509
- DOI: 10.2165/00148581-200608010-00002
Invasive aspergillosis in children with hematologic malignancies
Abstract
The respiratory tract is the most common system affected by aspergillosis in children with hematologic malignancies. However, Aspergillus spp. tend to invade blood vessels, resulting in systemic dissemination to multiple organs including, but not limited to, the brain, bones, liver, kidneys, and skin. Because early diagnosis and treatment are critical to the patient's outcome, a high index of suspicion should be maintained in children with hematologic malignancies who are neutropenic and have prolonged fever that is unresponsive to systemic antibacterials. Several diagnostic modalities should be used simultaneously in order to establish the diagnosis in an expeditious manner. Detailed radiographic evaluations with plain radiographs, and CT scans of the chest, sinuses, brain, and other organs should be performed as soon as clinical suspicion is raised. Detection of circulating antigens, such as galactomannan and 1,3-beta-glucan, and polymerase chain reaction appear promising in aiding in the diagnosis. A definitive diagnosis requires both a positive culture from a sterile site and evidence of tissue damage demonstrated by imaging studies or microscopic evaluations of sites of infection. Because the mortality rate is very high, empiric systemic antifungal therapy with amphotericin B, or one of its lipid formulations, should be initiated while laboratory investigations to substantiate or refute the diagnosis are continued. Surgical intervention is associated with a high mortality rate but may be of benefit in children with localized disease.
Similar articles
-
Treatment of invasive Aspergillosis in children with hematologic malignancies.Indian J Pediatr. 2004 Sep;71(9):837-43. doi: 10.1007/BF02730724. Indian J Pediatr. 2004. PMID: 15448392 Review.
-
Systemic fungal infections in patients with hematologic malignancies: indications and limitations of the antifungal armamentarium.Chemotherapy. 1999 Sep-Oct;45(5):315-24. doi: 10.1159/000007222. Chemotherapy. 1999. PMID: 10473919 Review.
-
An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group.J Infect. 1998 Sep;37(2):173-80. doi: 10.1016/s0163-4453(98)80173-4. J Infect. 1998. PMID: 9821093
-
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.Cancer. 2008 Mar 15;112(6):1282-7. doi: 10.1002/cncr.23311. Cancer. 2008. PMID: 18224662
-
Invasive Aspergillus infections in hematologic malignancy patients.Semin Respir Infect. 2002 Jun;17(2):99-105. doi: 10.1053/srin.2002.33443. Semin Respir Infect. 2002. PMID: 12070828 Review.
Cited by
-
Radiological patterns of pulmonary fungal infection in pediatric hematology and oncology patients.Radiol Bras. 2022 Mar-Apr;55(2):78-83. doi: 10.1590/0100-3984.2021.0055. Radiol Bras. 2022. PMID: 35414734 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous